Gainers
- Bluejay Diagnostics BJDX shares rose 126.3% to $7.99 during Monday's regular session. The company's market cap stands at $4.4 million.
- Artiva Biotherapeutics ARTV shares moved upwards by 35.04% to $3.29. The market value of their outstanding shares is at $80.2 million.
- Shuttle Pharmaceuticals SHPH shares moved upwards by 34.43% to $0.52. The company's market cap stands at $3.2 million.
- Shattuck Labs STTK shares increased by 32.3% to $0.97. The company's market cap stands at $46.4 million.
- Agape ATP ATPC stock rose 30.32% to $1.59. The market value of their outstanding shares is at $6.3 million.
- Sutro Biopharma STRO stock moved upwards by 28.13% to $0.69. The company's market cap stands at $58.1 million.
Losers
- iBio IBIO shares fell 43.0% to $1.84 during Monday's regular session. The market value of their outstanding shares is at $18.1 million.
- China Pharma Holding CPHI stock decreased by 39.91% to $0.13. The market value of their outstanding shares is at $2.5 million.
- Lexeo Therapeutics LXEO stock fell 29.32% to $1.65. The company's market cap stands at $54.7 million.
- Alumis ALMS stock decreased by 23.49% to $7.69. The company's market cap stands at $418.3 million.
- Aditxt ADTX stock fell 23.16% to $3.63. The market value of their outstanding shares is at $3.7 million.
- Sharps Technology STSS shares decreased by 22.87% to $0.02. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ADTXAditxt Inc
$3.64-23.0%
Edge Rankings
Momentum0.12
Growth-
Quality-
Value51.12
Price Trend
Short
Medium
Long
ALMSAlumis Inc
$7.69-23.5%
ARTVArtiva Biotherapeutics Inc
$3.4541.4%
ATPCAgape ATP Corp
$1.5224.6%
BJDXBluejay Diagnostics Inc
$8.18131.7%
CPHIChina Pharma Holding Inc
$0.1350-39.2%
IBIOiBio Inc
$1.80-44.2%
LXEOLexeo Therapeutics Inc
$2.527.92%
SHPHShuttle Pharmaceuticals Holdings Inc
$0.416812.9%
STROSutro Biopharma Inc
$0.678025.1%
STSSSharps Technology Inc
$0.0200-22.5%
STTKShattuck Labs Inc
$0.967332.0%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in